21 Novembre 2026

Psicologia Punto One | Psicologia e Psicologi nel Web

Menu

Menu

SCHEDA SCIENTIFICA2026Altra ricerca

Retinal nerve fibre layer, and ganglion cell layer thicknesses in children with ADHD: associations with subtypes and symptom severity.

Xiu Juan Zhang, Xiu Nian Chen, Yuzhou Zhang, Ka Wai Kam, Ian C K Wong, Wei Zhang, Alvin L Young, Clement C Tham, Chi Pui Pang, Li Jia Chen, Patrick Ip, Jason C Yam

BMC psychiatry · 2026

Abstract originale

BACKGROUND: To investigate retinal nerve fibre layer (RNFL) and ganglion cell layer (GCL) thickness in different attention-deficit/hyperactivity disorder (ADHD) subtypes and their association with ADHD symptom severity. METHODS: This is a cross-sectional study included children aged 6-8 years in Hong Kong. ADHD diagnoses were made by psychiatrists based on ICD-10 criteria. RESULTS: Among 6431 children included in the study, 309 (4.80%) were diagnosed with ADHD and 6122 served as controls. Children with ADHD showed thinner p-RNFL, m-GCL, and p-GCL than controls (P = 0.002; P = 0.03; P = 0.003, respectively). Among the 309 ADHD, 149 were categorized as the combined (C) type, 74 as the Inattentive (IA) type, 39 as the hyperactive/impulsive (HI) type. The ADHD-C subtype exhibited thinner p-RNFL (mean difference [MD] = -2.47, P = 0.03), m-GCL (MD = -1.10, P = 0.03), and p-GCL (MD = -0.85, P = 0.007) than controls. The p-RNFL, m-GCL, and p-GCL thicknesses showed a decreasing trend across ADHD subtypes, being thickest in the ADHD-HI, followed by the IA, and then the C subtype (P = 0.04, P = 0.005, and P = 0.04, respectively). Higher SWAN-combined scores were associated with thinner p-RNFL, m-GCL, p-GCL, and m-RNFL (P = 0.04; P = 0.002; P = 0.005; P = 0.02, respectively). CONCLUSION: RNFL and GCL thicknesses varied across ADHD subtypes. The combined subtypes exhibited thinner measurements than controls. An overall trend toward thinner RNFL and GCL thicknesses was observed across subtypes. RNFL and GCL thicknesses were negatively associated with severity of combined ADHD symptoms. CLINICAL TRIAL NUMBER: Not applicable.

Parole chiave

HumansAttention Deficit Disorder with HyperactivityChildFemaleMaleCross-Sectional StudiesRetinal Ganglion CellsNerve FibersSeverity of Illness IndexRetinaTomography, Optical CoherenceADHD subtypesGCL thicknessRNFL thickness
Leggi il testo integrale originale

Testo estratto dalla pubblicazione: sono esclusi immagini, media, supplementi e parti soggette a diritti distinti.

Retinal nerve fibre layer, and ganglion cell layer thicknesses in children with ADHD: associations with subtypes and symptom severity

Background

To investigate retinal nerve fibre layer (RNFL) and ganglion cell layer (GCL) thickness in different attention-deficit/hyperactivity disorder (ADHD) subtypes and their association with ADHD symptom severity.

Methods

This is a cross-sectional study included children aged 6–8 years in Hong Kong. ADHD diagnoses were made by psychiatrists based on ICD-10 criteria.

Results

Among 6431 children included in the study, 309 (4.80%) were diagnosed with ADHD and 6122 served as controls. Children with ADHD showed thinner p-RNFL, m-GCL, and p-GCL than controls (P = 0.002; P = 0.03; P = 0.003, respectively). Among the 309 ADHD, 149 were categorized as the combined (C) type, 74 as the Inattentive (IA) type, 39 as the hyperactive/impulsive (HI) type. The ADHD-C subtype exhibited thinner p-RNFL (mean difference [MD] = -2.47, P = 0.03), m-GCL (MD = -1.10, P = 0.03), and p-GCL (MD = -0.85, P = 0.007) than controls. The p-RNFL, m-GCL, and p-GCL thicknesses showed a decreasing trend across ADHD subtypes, being thickest in the ADHD-HI, followed by the IA, and then the C subtype (P = 0.04, P = 0.005, and P = 0.04, respectively). Higher SWAN-combined scores were associated with thinner p-RNFL, m-GCL, p-GCL, and m-RNFL (P = 0.04; P = 0.002; P = 0.005; P = 0.02, respectively).

Conclusion

RNFL and GCL thicknesses varied across ADHD subtypes. The combined subtypes exhibited thinner measurements than controls. An overall trend toward thinner RNFL and GCL thicknesses was observed across subtypes. RNFL and GCL thicknesses were negatively associated with severity of combined ADHD symptoms.

Clinical trial number

Not applicable.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1186/s12888-026-08422-1.

Background

Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most prevalent neurodevelopmental disorders in children, with global prevalence rates estimated at 6.7–7.8% among pediatric populations [1]. The disorder often persists into adulthood, affecting approximately 2.5% of adults [2]. Clinically, ADHD is categorized into three subtypes: predominantly inattentive (ADHD-IA), predominantly hyperactive-impulsive (ADHD-HI), and combined type (ADHD-C). The latter encompasses both inattentive and hyperactive-impulsive symptoms [3]. Although these subtypes share numerous overlapping characteristics and general treatment approaches, distinct differences exist in their management that are particularly evident in the implementation of tailored educational strategies and family support systems [4]. Early identification and differentiation of ADHD subtypes are critical for optimizing therapeutic outcomes and ensuring individualized care for affected individuals.

The diagnosis and identification of ADHD and its subtypes remain challenging, primarily due to difficulties in distinguishing symptom variability and the absence of objective diagnostic tools. Clinically, the measures currently used to assess ADHD are predominantly subjective, and there is limited understanding of the distinct pathophysiological mechanisms underlying each subtype [5, 6]. Neuroimaging studies have demonstrated that ADHD is associated with structural abnormalities in the brain [7–9]. The retina, particularly the retinal nerve fibre layer (RNFL) and ganglion cell layer (GCL), is considered as an extension of the central nervous system based on its embryonic origin from the diencephalon. It has been investigated as a potential biomarker for ADHD [10, 11]. However, most studies have focused on pooled ADHD populations without differentiating between subtypes, limiting the ability to identify subtype-specific biomarkers.

To address these gaps, we conducted a population-based, nested case-control study to investigate the associations between ADHD and its subtypes with RNFL or GCL thicknesses in children.

Methods

Study design and population

The present study analyzed a subset from the ongoing Hong Kong Children Eye Study, which is a population-based and territory-wide study of eye conditions in Hong Kong children [12]. Children were invited to the Chinese University of Hong Kong Eye Centre for comprehensive ocular examinations and answered a standardized questionnaires according to the unified protocol. The current study excluded children with any systemic diseases (except obesity and ADHD) and ocular diseases (except refractive errors). The study adhered to the Declaration of Helsinki, and ethical approval was obtained from the Institutional Review Board of the Chinese University of Hong Kong. All children and their parents signed an informed consent form upon participating in the study.

OCT imaging

OCT imaging was performed by Swept-source optical coherence tomography (SS-OCT) (DRI Triton; T Topcon Inc., Tokyo, Japan) in a dark room after pupil dilation. The SS-OCT incorporates a light source at 1,050 nm wavelength and operates at a speed of 100,000 A-scans per second. Peripapillary RNFL (p-RNFL) thickness was measured by a peripapillary circle scan in a 3.4-mm diameter section around the optic nerve disc. The evaluated p-RNFL thickness parameters were average thickness, RNFL by quadrant, and 12 clock-hour sectors. Likewise, the topographical data of GCL was evaluated. The macular RNFL (m-RNFL) and macular GCL (m-GCL) thickness were measured in the following 6 sectors around the macula foveal center: nasal superior, superior, temporal superior, temporal inferior, inferior, and nasal inferior regions. Images with poor quality and signal strength index (SSI) < 50 were excluded.

Identification of children with ADHD and assessment of ADHD symptoms

As described in our previous study, ADHD diagnoses and prescription records were retrieved from the Hong Kong Hospital Authority (HA) Electronic Medical Record (EMR) system and were established by psychiatrists based on ICD-10 criteria [13]. Participants diagnosed with ADHD were included in the ADHD group, whereas those without ADHD served as controls. Children with ADHD who had been treated with methylphenidate or amphetamine for at least one month prior to the OCT examination were defined as having a stimulant treatment history. Regarding ADHD subtype information, subtype classification is not mandatory, and documentation practices vary among psychiatrists, which has led to a lack of subtype data in the EMR system. Therefore, we used the parent-reported Strengths and Weaknesses of ADHD-Symptoms and Normal-Behaviors Questionnaire (SWAN) questionnaire to classify ADHD subtypes [14, 15].

The SWAN consists of 18 items rated on a 7-point scale. The average score across all items provides the ADHD-combined score, while the averages of the first nine and last nine items yield the inattentive and hyperactive/impulsive subscale scores, respectively, with higher scores indicating more severe symptoms [16]. The SWAN scale has been validated in the Hong Kong population. Cutoff scores for subtypes have been established by psychiatrists, with thresholds of 0.72 and 0.83 for IA and HI, respectively, among males, and 0.94 and 0.61 among females. Participants were classified as the ADHD-C if both criteria were met [15]. In this study, we applied these established cutoff values to classify ADHD subtypes among children with psychiatrist-diagnosed ADHD.

Ocular examinations

Ocular biometry, including axial length (AL), was measured through noncontact partial-coherence laser interferometry (IOL Master; Carl Zeiss Meditec, Oberkochen, Germany). Refractive status was measured both before and after cycloplegia using an auto-refractor (Nidek ARK-510 A, Gamagori, Japan) for each child. An ophthalmologist made detailed examinations of the anterior segment using a slit-lamp (Haag-Streit, Koeniz, Switzerland) and the retina using a 20-D lens (Volk, Houston, TX).

Statistical analysis

Continuous variables are reported as means with standard deviations (SDs), and categorical variables as counts with percentages. Group comparisons were performed using chi-square tests for categorical variables. For normally distributed continuous variables, Student’s t-tests were used for comparisons between two groups, and analysis of variance (ANOVA) for comparisons among more than two groups. Analyses of spherical equivalent, axial length, and RNFL and GCL thickness were performed using binocular data. Generalized estimating equations (GEE) were employed to account for inter-eye correlations within participants. GEE linear regression models were used: (1) to compare RNFL and GCL thicknesses between the ADHD subtypes and control groups, and (2) to assess associations between RNFL and GCL thicknesses and the severity of ADHD symptoms. These models were adjusted for age, sex, and AL. For comparisons among the three ADHD subtypes and controls, a GEE linear regression model was fitted, and post hoc pairwise comparisons were performed with false discovery rate (FDR) method. All statistical analyses were conducted using R software (version 4.5.2). A two-sided P-value of less than 0.05 was considered statistically significant.

Results

RNFL and GCL thicknesses in children diagnosed as ADHD

A total of 6431 children were included, comprising 309 (4.80%) children diagnosed with ADHD and 6122 children as controls, mean age of ADHD children was 7.48 ± 0.92 years, compared to 7.28 ± 0.94 years of the controls (P < 0.001). The proportion of males was significantly higher in the ADHD group (76.70%) than in the control group (49.71%) (P < 0.001) (Table 1). Among the ADHD group, 53 cases (17.15%) had a stimulant treatment history. Children with ADHD showed thinner p-RNFL (110.48 ± 13.18 vs. 112.35 ± 12.06, P = 0.002) than controls after adjusting for age, sex and AL. Similarly, thinner m-GCL (78.73 ± 6.15 vs. 79.14 ± 5.95, P = 0.03) and p-GCL (42.67 ± 4.45 vs. 43.28 ± 4.57, P = 0.003) were observed in ADHD (Table 1).

Table 1Basic information and RNFL and GCL thicknesses in ADHD and controls

ADHD (n = 309) Control (n = 6122) P value

Age, mean (SD), year 7.48 (0.92) 7.28 (0.94) < 0.001

Male, No. (%) 237 (76.70) 3042 (49.71) < 0.001

Axial lengtha, mean (SD), mm 23.16 (0.98) 23.02 (0.93) 0.03

Spherical equivalenta, mean (SD), diopter 0.01 (1.75) 0.22 (1.48) 0.22

p-RNFLb, mean (SD), um 110.48 (13.18) 112.35 (12.06) 0.002

m-GCLb, mean (SD), um 78.73 (6.15) 79.14 (5.95) 0.03

p-GCLb, mean (SD), um 42.67 (4.45) 43.28 (4.57) 0.003

m-RNFLb, mean (SD), um 31.56 (2.93) 31.77 (2.63) 0.06

a Using binocular data and correcting for binocular correlation with GEE model, adjusted for age and sex. b Using binocular data and correcting for binocular correlation with GEE model, adjusted for age, sex and axial length

RNFL and GCL thicknesses in ADHD subtypes

Among the 309 children with ADHD, 149 were categorized as the ADHD-C type, 74 as the IA type, 39 as the HI type. The remaining 47 children could not be categorized, as their SWAN subscale scores fell below the predefined cutoff thresholds and were therefore excluded from the subtype analysis. Comparisons between these 47 unclassifiable ADHD and children with classified ADHD subtypes showed no differences in OCT parameters (Supplementary Table 1). Overall comparisons revealed significant differences in p-RNFL, m-GCL, and p-GCL thicknesses among the three ADHD subtypes and controls (P = 0.02, P = 0.009, P = 0.01, respectively) (Table 2).

Table 2Basic information and RNFL and GCL thicknesses among ADHD subtypes and controls

(1) ADHD-C (n = 149) (2) ADHD-IA (n = 74) (3) ADHD-HI (n = 39) (4) Control (n = 6122) P valuec

Age, mean (SD), year 7.40 (0.86) 7.64 (0.93) 7.29 (1.00) 7.28 (0.94) 0.005

Male, No. (%) 118 (79.19) 59 (79.73) 21 (53.85) 3043 (49.71) < 0.001

Axial lengtha, mean (SD), mm 23.15 (0.97) 23.05 (1.10) 23.06 (0.91) 23.02 (0.93) 0.02

Spherical equivalenta, mean (SD), diopter 0.01 (1.68) 0.18 (1.94) 0.18 (1.39) 0.22 (1.48) 0.52

P-RNFLb, mean (SD), um 109.66 (15.02) 110.98 (11.09) 112.75 (10.34) 112.35 (12.06) 0.02

(1) vs. (4) Pd = 0.03

m-GCLb, mean (SD), um 78.20 (7.21) 78.97 (4.21) 80.10 (5.06) 79.14 (5.95) 0.009

(1) vs. (4) Pd = 0.03

(1) vs. (3) Pd = 0.02

(2) vs. (3) Pd = 0.04

p-GCLb, mean (SD), um 42.36 (4.54) 42.99 (4.33) 43.39 (4.76) 43.28 (4.57) 0.01

(1) vs. (4) Pd = 0.008

m-RNFLb, mean (SD), um 31.47 (3.64) 31.47 (1.93) 32.05 (2.03) 31.77 (2.63) 0.11

ADHD-C: combined ADHD subtype, ADHD-IA: inattentive ADHD subtype, ADHD-HI: hyperactive/impulsive ADHD subtype. a Using binocular data and correcting for binocular correlation with GEE model, adjusted for age and sex. b Using binocular data and correcting for binocular correlation with GEE model, adjusted for age, sex and axial length. c P values refer to overall comparisons across the four groups. d Post hoc pairwise comparisons with significance are presented after FDR adjustment

In post-hoc pairwise comparisons with FDR correction, the ADHD-C subtype exhibited significantly thinner p-RNFL (mean difference [MD] = -2.47, P = 0.03), m-GCL (MD = -1.10, P = 0.03), and p-GCL (MD = -0.85, P = 0.007) than controls. The ADHD-HI subtype showed thicker m-GCL than the ADHD-C (MD = 2.05, P = 0.02) and the ADHD-IA (MD = 1.47, P = 0.04) (Table 2; Fig. 1). The p-RNFL, m-GCL, and p-GCL thicknesses showed a decreasing trend across ADHD subtypes, being thickest in ADHD-HI, followed by the IA, and then the C subtype (P = 0.04, P = 0.005, and P = 0.04, respectively). The RNFL and GCL thicknesses in the superior, inferior, nasal, and temporal regions of the peripapillary and macular areas among ADHD subtypes and controls are presented in Table 3.

Table 3Subregions RNFL and GCL thicknesses among ADHD subtypes and controls

(1) ADHD-C (n = 149) (2) ADHD-IA (n = 74) (3) ADHD-HI (n = 39) (4) Control (n = 6122) P valueb

p-RNFLa, mean (SD), um

Superior Region 141.28 (22.62) 143.83 (20.82) 144.36 (16.06) 144.03 (20.14) 0.22

Inferior Region 140.16 (25.15) 140.49 (16.28) 143.43 (16.05) 143.55 (20.30) 0.02

Nasal Region 72.99 (15.64) 74.46 (12.60) 73.03 (14.93) 75.08 (14.44) 0.04

Temporal Region 84.20 (15.05) 85.15 (11.19) 90.05 (15.52) 86.64 (13.68) 0.02

(1) vs. (3) Pc = 0.03

m-GCLa, mean (SD), um

Superior Region 78.15 (8.14) 79.20 (4.74) 80.57 (4.88) 79.64 (6.48) < 0.001

(1) vs. (4) Pc = 0.003

(1) vs. (3) Pc = 0.003

(2) vs. (3) Pc = 0.02

Inferior Region 76.50 (7.20) 77.07 (4.43) 78.11 (4.95) 77.36 (6.18) 0.03

Nasal Region 80.96 (9.06) 81.53 (5.50) 82.51 (6.50) 81.51 (8.03) 0.27

Temporal Region 77.19 (9.18) 78.09 (5.86) 79.20 (5.45) 78.03 (7.44) 0.03

(1) vs. (3) Pc = 0.03

p-GCLa, mean (SD), um

Superior Region 39.25 (6.27) 40.06 (5.37) 40.85 (6.05) 40.38 (6.07) 0.01

(1) vs. (4) Pc = 0.01

Inferior Region 38.02 (5.58) 39.20 (7.19) 39.48 (5.61) 39.19 (5.62) 0.01

(1) vs. (4) Pc = 0.006

Nasal Region 41.81 (5.42) 42.27 (3.74) 42.54 (5.77) 42.57 (4.92) 0.17

Temporal Region 50.37 (6.68) 50.48 (5.21) 50.47 (7.39) 50.99 (7.41) 0.28

m-RNFLa, mean (SD), um

Superior Region 32.77 (4.91) 33.14 (2.31) 33.79 (2.66) 33.45 (3.30) 0.11

Inferior Region 34.16 (3.77) 34.10 (2.81) 34.80 (2.70) 34.50 (3.65) 0.20

Nasal Region 36.13 (5.86) 36.00 (3.02) 36.88 (3.04) 36.34 (4.05) 0.20

Temporal Region 22.71 (3.06) 22.64 (1.36) 22.71 (0.92) 22.79 (1.96) 0.44

ADHD-C: combined ADHD subtype, ADHD-IA: inattentive ADHD subtype, ADHD-HI: hyperactive/impulsive ADHD subtype. a Using binocular data and correcting for binocular correlation with GEE model, adjusted for age, sex and axial length. b P values refer to overall comparisons across the four groups. c Post hoc pairwise comparisons with significance are presented after FDR adjustment

Association between severity of ADHD symptoms and RNFL and GCL thicknesses

Among the overall population, higher SWAN-combined scores was associated with thinner p-RNFL (β = -0.21 μm/score, P = 0.04), m-GCL (β = -0.15 μm/score, P = 0.002), p-GCL (β = -0.12 μm/score, P = 0.005), and m-RNFL thicknesses (β = -0.05 μm/score, P = 0.02) (Table 4). In contrast, SWAN-inattentive scores showed borderline but non-significant associations with thinner m-GCL (β = -0.13 μm/score, P = 0.07), p-GCL (β = -0.11 μm/score, P = 0.09), and m-RNFL (β = -0.06 μm/score, P = 0.06). No significant associations were observed between SWAN-hyperactivity/impulsivity scores and RNFL or GCL thickness (Table 4).

Table 4Association between severity of ADHD symptoms and RNFL and GCL thicknesses

p-RNFL m-GCL p-GCL m-RNFL

β (95% CI) P valuea β (95% CI) P valuea β (95% CI) P valuea β (95% CI) P valuea

SWAN combined Scoreb, c -0.21 (-0.41 to -0.01) 0.04 -0.15 (-0.24 to -0.05) 0.002 -0.12 (-0.20 to -0.03) 0.005 -0.05 (-0.09 to -0.01) 0.02

SWAN Inattentive Scoreb, d -0.24 (-0.54 to 0.05) 0.11 -0.13 (-0.27 to 0.01) 0.07 -0.11 (-0.23 to 0.02) 0.09 -0.06 (-0.12 to 0.002) 0.06

SWAN Hyperactivive/Impulsive Scoreb, d 0.01 (-0.25 to 0.27) 0.93 -0.02 (-0.15 to 0.10) 0.73 -0.02 (-0.13 to 0.10) 0.79 0.004 (-0.05 to 0.06) 0.89

a Analyses based on full-population binocular data, using GEE model to correct for interocular correlation. b The SWAN combined score was calculated as the mean of all 18 items. The inattention score was calculated as the mean of the first nine items, and the hyperactivity/impulsivity score was calculated as the mean of the last nine items. C Combined scores were included as the independent variable, with RNFL and GCL thickness as dependent variables, adjusting for age, sex, and axial length. d Inattentive and hyperactive/impulsive scores were included as the independent variable in one model, with RNFL and GCL thickness as dependent variables, adjusting for age, sex, and axial length

Discussion

In this study, we found that RNFL and GCL thicknesses were reduced in children with ADHD. Notably, we observed variations in these changes across different ADHD subtypes. ADHD-C exhibited thinner RNFL and GCL than controls. RNFL and GCL thicknesses appeared to decrease across subtypes; however, given the unbalanced group sizes and limited effective size, these findings should be interpreted with caution. Confirmatory studies with larger ADHD-HI samples are needed before any biological interpretation can be made. Furthermore, RNFL and GCL thicknesses were negatively correlated with the severity of ADHD symptoms. Taken together, our data reveal that RNFL and GCL thicknesses are significantly associated with ADHD, with variations observed across subtypes and symptom severity. Differences in these retinal layers between ADHD subtypes may help elucidate their underlying pathophysiology. These findings provide preliminary evidence supporting further investigation of retinal indices as potential biomarkers of ADHD.

This study used the retina as a platform to study disorders in the central nerve system (CNS) because it is an accessible extension of the brain in terms of embryology, anatomy, and physiology [10]. Emerging evidence suggests an association between ADHD and neuropathology, similar to seizure disorders [17–19]. The RNFL contains ganglion cells with unmyelinated axons, which are considered to be an extension of the cerebral gray matter. Our findings of RNFL and GCL thinning in ADHD children align with previous MRI findings of reduced cerebral gray matter in individuals with ADHD [20–23]. Hergüner et al. also found that reduced RNFL thickness in children with ADHD [24]. Children and adolescents with ADHD and Oppositional Defiant Disorder (ODD) accompanying ADHD had reportedly thinner GCL [25].

Not much information has been reported on the differences of retinal morphometric imaging between subtypes of ADHD. Clinically, ADHD-C is the most common subtype, whereas ADHD-HI is relatively rare. The symptoms of these subtypes differ significantly. ADHD-IA is characterized by symptoms of distractibility, forgetfulness, and difficulty sustaining attention, which are markedly different from the hyperactivity and impulsivity observed in ADHD-HI. Moreover, these subtypes may possess distinct neuroanatomical and functional profiles [26–28]. A case-control study reported that the severe-combined with emotional dysregulation ADHD exhibited widespread medial prefrontal cortex-pallidum alterations, whereas the predominantly hyperactive/impulsive ADHD demonstrated anterior cingulate cortex-pallidum circuit alterations, and the predominantly inattentive ADHD showed superior frontal gyrus alterations [29]. Semrud-Clikeman et al. found that ADHD combined children had bilaterally smaller volumes of the caudate and anterior cingulate cortex than neurotypical peers [30]. Similarly, ShuHua et al. reported decreased subcortical volume in patients with ADHD combined type compared with neurotypical peers [31]. These results are consistent with our finding that children with ADHD-C had thinner RNFL and GCL thicknesses than controls. We speculate that the differences in RNFL and GCL thicknesses among ADHD subtypes reflect variations in underlying neurodevelopmental processes. Further research and validation are warranted to confirm these findings and elucidate the underlying mechanisms.

We found that RNFL and GCL thicknesses were negatively associated with the severity of ADHD symptoms. In a cohort study of 2235 healthy cases, there was association between thinner RNFL and Ganglion Cell Complex (GCC) with lower gray matter density in the primary visual cortex [32]. Retinal thinning observed in ADHD may reflect alterations in neuronal integrity along the visual pathway. While anterograde degeneration has been proposed as one possible mechanism [33], alternative explanations include broader neurodevelopmental alterations associated with ADHD, as well as retrograde transsynaptic effects from central visual and attentional networks [34]. Interestingly, when analyzed separately by symptom domains, the observed effect appeared to be primarily driven by inattentive symptoms, showing a borderline significance, whereas no association was found for hyperactive/impulsive symptoms. Study have reported increased grey matter volume (GMV) involving the frontal regions and cerebellum with increasing inattentiveness severity [35]. In contrast, greater overall ADHD severity has been associated with grey matter atrophy in regions including the cerebellum and hippocampus. These findings suggest that brain structural alterations in ADHD may be heterogeneous and dependent on symptom domain and severity, which may partly explain the observed retinal changes. Further studies are needed to elucidate the underlying mechanisms.

Strengths of the present study are the large sample size and population-based design. The diagnosis of ADHD was confirmed by psychiatrists according to ICD-10 criteria [36]. This sample size enables the generalizability of our findings among different subtypes of ADHD. However, there are several limitations in current study. First, ADHD subtypes were classified using the SWAN questionnaire. Although the SWAN is a well-validated instrument, some degree of misclassification is possible because subtype assignment was based on parent-reported symptoms rather than clinician-determined diagnoses. Second, a proportion of children with ADHD had a history of stimulant treatment. Although stimulant use did not influence the association between ADHD subtypes and OCT indices in the primary analysis and was therefore not included in the final analysis, its potential impact on OCT indices cannot be completely ruled out. Future longitudinal studies are warranted to further clarify the relationship between stimulant treatment and retinal structural changes. Third, while this study examined retinal thickness across ADHD subtypes, reverse causation and shared underlying neurodevelopmental factors cannot be ruled out. Longitudinal studies and mechanistic investigations are needed to clarify these relationships. Lastly, the observed group differences and associations, although statistically significant, were relatively modest in magnitude. Therefore, the interpretation of the clinical meaning needs to be cautious.

In conclusion, RNFL and GCL thickness varied across ADHD subtypes. The combined subtypes exhibited significantly thinner measurements than controls. An overall trend toward thinner RNFL and GCL thicknesses was observed across subtypes. Furthermore, RNFL and GCL thickness were negatively associated with severity of combined ADHD symptoms. These findings, which may help elucidate the pathophysiology of ADHD subtypes, provide preliminary evidence supporting further investigation of retinal indices as potential biomarkers of ADHD.

Supplementary Information

Below is the link to the electronic supplementary material.

References

1.Thomas R Sanders S Doust J Beller E Glasziou P Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis Pediatrics 2015 135 4 e994 1001 10.1542/peds.2014-3482 25733754 Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994–1001.10.1542/peds.2014-3482 25733754

2.Usami M Functional consequences of attention-deficit hyperactivity disorder on children and their families Psychiatry Clin Neurosci 2016 70 8 303 17 10.1111/pcn.12393 27061213 Usami M. Functional consequences of attention-deficit hyperactivity disorder on children and their families. Psychiatry Clin Neurosci. 2016;70(8):303–17.10.1111/pcn.12393 27061213

3.Posner J Polanczyk GV Sonuga-Barke E Attention-deficit hyperactivity disorder Lancet 2020 395 10222 450 62 10.1016/S0140-6736(19)33004-1 31982036 Posner J, Polanczyk GV, Sonuga-Barke E. Attention-deficit hyperactivity disorder. Lancet. 2020;395(10222):450–62.10.1016/S0140-6736(19)33004-1 PMC7880081 31982036

4.Barbaresi WJ Katusic SK Colligan RC Weaver AL Leibson CL Jacobsen SJ Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study J Dev Behav Pediatr 2006 27 1 1 10 10.1097/00004703-200602000-00001 16511362 Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr. 2006;27(1):1–10.10.1097/00004703-200602000-00001 16511362

5.Albrecht B Uebel-von Sandersleben H Gevensleben H Rothenberger A Pathophysiology of ADHD and associated problems-starting points for NF interventions? Front Hum Neurosci 2015 9 359 10.3389/fnhum.2015.00359 26157377 Albrecht B, Uebel-von Sandersleben H, Gevensleben H, Rothenberger A. Pathophysiology of ADHD and associated problems-starting points for NF interventions? Front Hum Neurosci. 2015;9:359.10.3389/fnhum.2015.00359 PMC4478393 26157377

6.Wilens TE Spencer TJ Understanding attention-deficit/hyperactivity disorder from childhood to adulthood Postgrad Med 2010 122 5 97 109 10.3810/pgm.2010.09.2206 20861593 Wilens TE, Spencer TJ. Understanding attention-deficit/hyperactivity disorder from childhood to adulthood. Postgrad Med. 2010;122(5):97–109.10.3810/pgm.2010.09.2206 PMC3724232 20861593

7.Castellanos FX Lee PP Sharp W Jeffries NO Greenstein DK Clasen LS Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder JAMA 2002 288 14 1740 8 10.1001/jama.288.14.1740 12365958 Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA. 2002;288(14):1740–8.10.1001/jama.288.14.1740 12365958

8.Krain AL Castellanos FX Brain development and ADHD Clin Psychol Rev 2006 26 4 433 44 10.1016/j.cpr.2006.01.005 16480802 Krain AL, Castellanos FX. Brain development and ADHD. Clin Psychol Rev. 2006;26(4):433–44.10.1016/j.cpr.2006.01.005 16480802

9.Shaw P Malek M Watson B Sharp W Evans A Greenstein D Development of cortical surface area and gyrification in attention-deficit/hyperactivity disorder Biol Psychiatry 2012 72 3 191 7 10.1016/j.biopsych.2012.01.031 22418014 Shaw P, Malek M, Watson B, Sharp W, Evans A, Greenstein D. Development of cortical surface area and gyrification in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2012;72(3):191–7.10.1016/j.biopsych.2012.01.031 PMC10376909 22418014

10.London A Benhar I Schwartz M The retina as a window to the brain-from eye research to CNS disorders Nat Rev Neurol 2013 9 1 44 53 10.1038/nrneurol.2012.227 23165340 London A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol. 2013;9(1):44–53.10.1038/nrneurol.2012.227 23165340

11.MacCormick IJ Czanner G Faragher B Developing retinal biomarkers of neurological disease: an analytical perspective Biomark Med 2015 9 7 691 701 10.2217/bmm.15.17 26174843 MacCormick IJ, Czanner G, Faragher B. Developing retinal biomarkers of neurological disease: an analytical perspective. Biomark Med. 2015;9(7):691–701.10.2217/bmm.15.17 PMC4822679 26174843

12.Yam JC Tang SM Kam KW Chen LJ Yu M Law AK High prevalence of myopia in children and their parents in Hong Kong Chinese Population: the Hong Kong Children Eye Study Acta Ophthalmol 2020 98 5 e639 48 10.1111/aos.14350 31981300 Yam JC, Tang SM, Kam KW, Chen LJ, Yu M, Law AK, et al. High prevalence of myopia in children and their parents in Hong Kong Chinese Population: the Hong Kong Children Eye Study. Acta Ophthalmol. 2020;98(5):e639–48.10.1111/aos.14350 31981300

13.Chen XN Zhang XJ Zhang Y Tang F Kam KW Ng MPH Association of Attention-Deficit Hyperactivity Disorder With Myopia Among School Children Invest Ophthalmol Vis Sci 2025 66 9 36 10.1167/iovs.66.9.36 40657972 Chen XN, Zhang XJ, Zhang Y, Tang F, Kam KW, Ng MPH, et al. Association of Attention-Deficit Hyperactivity Disorder With Myopia Among School Children. Invest Ophthalmol Vis Sci. 2025;66(9):36.10.1167/iovs.66.9.36 PMC12270027 40657972

14.Lai KY Leung PW Luk ES Wong AS Law LS Ho KK Validation of the Chinese strengths and weaknesses of ADHD-symptoms and normal-behaviors questionnaire in Hong Kong J Atten Disord 2013 17 3 194 202 10.1177/1087054711430711 22210800 Lai KY, Leung PW, Luk ES, Wong AS, Law LS, Ho KK. Validation of the Chinese strengths and weaknesses of ADHD-symptoms and normal-behaviors questionnaire in Hong Kong. J Atten Disord. 2013;17(3):194–202.10.1177/1087054711430711 22210800

15.Chan GF Lai KY Luk ES Hung SF Leung PW Clinical utility of the Chinese Strengths and Weaknesses of ADHD-Symptoms and Normal-Behaviors questionnaire (SWAN) when compared with DISC-IV Neuropsychiatr Dis Treat 2014 10 1533 42 10.2147/NDT.S65879 25187717 Chan GF, Lai KY, Luk ES, Hung SF, Leung PW. Clinical utility of the Chinese Strengths and Weaknesses of ADHD-Symptoms and Normal-Behaviors questionnaire (SWAN) when compared with DISC-IV. Neuropsychiatr Dis Treat. 2014;10:1533–42.10.2147/NDT.S65879 PMC4149382 25187717

16.Swanson JM Schuck S Porter MM Carlson C Hartman CA Sergeant JA Categorical and Dimensional Definitions and Evaluations of Symptoms of ADHD: History of the SNAP and the SWAN Rating Scales Int J Educ Psychol Assess 2012 10 1 51 70 26504617 Swanson JM, Schuck S, Porter MM, Carlson C, Hartman CA, Sergeant JA, et al. Categorical and Dimensional Definitions and Evaluations of Symptoms of ADHD: History of the SNAP and the SWAN Rating Scales. Int J Educ Psychol Assess. 2012;10(1):51–70.PMC4618695 26504617

17.Fan HC, Chiang KL, Chang KH, Chen CM, Tsai JD. Epilepsy and attention deficit hyperactivity disorder: connection, chance, and challenges. Int J Mol Sci. 2023;24(6).10.3390/ijms24065270 PMC10049646 36982345

18.Williams AE Giust JM Kronenberger WG Dunn DW Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges Neuropsychiatr Dis Treat 2016 12 287 96 26929624 10.2147/NDT.S81549 Williams AE, Giust JM, Kronenberger WG, Dunn DW. Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges. Neuropsychiatr Dis Treat. 2016;12:287–96.10.2147/NDT.S81549 PMC4755462 26929624

19.Ahmed GK, Darwish AM, Khalifa H, Haridy NA. Relationship between attention deficit hyperactivity disorder and epilepsy: a literature review. Egypt J Neurol Psychiatry Neurosurg. 2022;58(1).10.1186/s41983-022-00494-6 PMC9125342 35645553

20.Mostofsky SH Cooper KL Kates WR Denckla MB Kaufmann WE Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder Biol Psychiatry 2002 52 8 785 94 10.1016/S0006-3223(02)01412-9 12372650 Mostofsky SH, Cooper KL, Kates WR, Denckla MB, Kaufmann WE. Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2002;52(8):785–94.10.1016/s0006-3223(02)01412-9 12372650

21.Casey BJ Castellanos FX Giedd JN Marsh WL Hamburger SD Schubert AB Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 1997 36 3 374 83 10.1097/00004583-199703000-00016 9055518 Casey BJ, Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Schubert AB, et al. Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997;36(3):374–83.10.1097/00004583-199703000-00016 9055518

22.Qiu A Crocetti D Adler M Mahone EM Denckla MB Miller MI Basal ganglia volume and shape in children with attention deficit hyperactivity disorder Am J Psychiatry 2009 166 1 74 82 10.1176/appi.ajp.2008.08030426 19015232 PMC2890266 Qiu A, Crocetti D, Adler M, Mahone EM, Denckla MB, Miller MI, et al. Basal ganglia volume and shape in children with attention deficit hyperactivity disorder. Am J Psychiatry. 2009;166(1):74–82.10.1176/appi.ajp.2008.08030426 PMC2890266 19015232

23.Batty MJ Liddle EB Pitiot A Toro R Groom MJ Scerif G Cortical gray matter in attention-deficit/hyperactivity disorder: a structural magnetic resonance imaging study J Am Acad Child Adolesc Psychiatry 2010 49 3 229 38 20410712 10.1016/j.jaac.2009.11.008 Batty MJ, Liddle EB, Pitiot A, Toro R, Groom MJ, Scerif G, et al. Cortical gray matter in attention-deficit/hyperactivity disorder: a structural magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry. 2010;49(3):229–38.10.1016/j.jaac.2009.11.008 PMC2829134 20410712

24.Hergüner A Alpfidan İ Yar A Erdoğan E Metin Ö Sakarya Y Retinal Nerve Fiber Layer Thickness in Children With ADHD J Atten Disord 2018 22 7 619 26 10.1177/1087054716664412 27535944 Hergüner A, Alpfidan İ, Yar A, Erdoğan E, Metin Ö, Sakarya Y, et al. Retinal Nerve Fiber Layer Thickness in Children With ADHD. J Atten Disord. 2018;22(7):619–26.10.1177/1087054716664412 27535944

25.Bodur S Kara H Açikel B Yasar E Evaluation of the ganglion cell layer thickness in children with attention deficit hyperactivity disorder and comorbid oppositional defiant disorder Klinik Psikiyatri Dergisi-Turkish J Clin Psychiatry 2018 21 3 222 30 Bodur S, Kara H, Açikel B, Yasar E. Evaluation of the ganglion cell layer thickness in children with attention deficit hyperactivity disorder and comorbid oppositional defiant disorder. Klinik Psikiyatri Dergisi-Turkish J Clin Psychiatry. 2018;21(3):222–30.

26.Milich R Balentine AC Lynam DR ADHD combined type and ADHD predominantly inattentive type are distinct and unrelated disorders Clin Psychology-Science Pract 2001 8 4 463 88 10.1093/clipsy.8.4.463 Milich R, Balentine AC, Lynam DR. ADHD combined type and ADHD predominantly inattentive type are distinct and unrelated disorders. Clin Psychology-Science Pract. 2001;8(4):463–88.

27.Diamond A Attention-deficit disorder (attention-deficit/ hyperactivity disorder without hyperactivity): a neurobiologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity) Dev Psychopathol 2005 17 3 807 25 10.1017/S0954579405050388 16262993 Diamond A. Attention-deficit disorder (attention-deficit/ hyperactivity disorder without hyperactivity): a neurobiologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity). Dev Psychopathol. 2005;17(3):807–25.10.1017/S0954579405050388 PMC1474811 16262993

28.Johnson S Marlow N Preterm birth and childhood psychiatric disorders Pediatr Res 2011 69 5 Pt 2 r11 8 10.1203/PDR.0b013e318212faa0 21289534 Johnson S, Marlow N. Preterm birth and childhood psychiatric disorders. Pediatr Res. 2011;69(5 Pt 2):r11–8.10.1203/PDR.0b013e318212faa0 21289534

29.Pan N Long Y Qin K Pope IZ Chen Q Zhu Z Mapping ADHD Heterogeneity and Biotypes by Topological Deviations in Morphometric Similarity Networks JAMA Psychiatry 2026 83 5 478 90 10.1001/jamapsychiatry.2026.0001 41739459 Pan N, Long Y, Qin K, Pope IZ, Chen Q, Zhu Z, et al. Mapping ADHD Heterogeneity and Biotypes by Topological Deviations in Morphometric Similarity Networks. JAMA Psychiatry. 2026;83(5):478–90.10.1001/jamapsychiatry.2026.0001 PMC12936971 41739459

30.Semrud-Clikeman M Fine JG Bledsoe J Zhu DC Regional Volumetric Differences Based on Structural MRI in Children With Two Subtypes of ADHD and Controls J Atten Disord 2017 21 12 1040 9 10.1177/1087054714559642 25488955 Semrud-Clikeman M, Fine JG, Bledsoe J, Zhu DC. Regional Volumetric Differences Based on Structural MRI in Children With Two Subtypes of ADHD and Controls. J Atten Disord. 2017;21(12):1040–9.10.1177/1087054714559642 25488955

31.Mu S Wu H Zhang J Chang C Structural Brain Changes and Associated Symptoms of ADHD Subtypes in Children Cereb Cortex 2022 32 6 1152 8 10.1093/cercor/bhab276 34409439 Mu S, Wu H, Zhang J, Chang C. Structural Brain Changes and Associated Symptoms of ADHD Subtypes in Children. Cereb Cortex. 2022;32(6):1152–8.10.1093/cercor/bhab276 34409439

32.Mutlu U Ikram MK Roshchupkin GV Bonnemaijer PWM Colijn JM Vingerling JR Thinner retinal layers are associated with changes in the visual pathway: A population-based study Hum Brain Mapp 2018 39 11 4290 301 10.1002/hbm.24246 29935103 Mutlu U, Ikram MK, Roshchupkin GV, Bonnemaijer PWM, Colijn JM, Vingerling JR, et al. Thinner retinal layers are associated with changes in the visual pathway: A population-based study. Hum Brain Mapp. 2018;39(11):4290–301.10.1002/hbm.24246 PMC6866563 29935103

33.Herro AM Lam BL Retrograde degeneration of retinal ganglion cells in homonymous hemianopsia Clin Ophthalmol 2015 9 1057 64 10.2147/OPTH.S81749 26089638 Herro AM, Lam BL. Retrograde degeneration of retinal ganglion cells in homonymous hemianopsia. Clin Ophthalmol. 2015;9:1057–64.10.2147/OPTH.S81749 PMC4468984 26089638

34.Dinkin M Trans-synaptic Retrograde Degeneration in the Human Visual System: Slow, Silent, and Real Curr Neurol Neurosci Rep 2017 17 2 16 10.1007/s11910-017-0725-2 28229400 Dinkin M. Trans-synaptic Retrograde Degeneration in the Human Visual System: Slow, Silent, and Real. Curr Neurol Neurosci Rep. 2017;17(2):16.10.1007/s11910-017-0725-2 28229400

35.Zhong T Wang F Qiu J Lu W Brain morphological changes across behaviour spectrums in attention-deficit/hyperactivity disorder Gen Psychiatr 2025 38 6 e102340 10.1136/gpsych-2025-102340 41458230 Zhong T, Wang F, Qiu J, Lu W. Brain morphological changes across behaviour spectrums in attention-deficit/hyperactivity disorder. Gen Psychiatr. 2025;38(6):e102340.10.1136/gpsych-2025-102340 PMC12742076 41458230

36.The ICD-10classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines 1992 GenevaWorld Health OrganizationThe ICD-10. classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.

Come citare questo studio

Xiu Juan Zhang, Xiu Nian Chen, Yuzhou Zhang, Ka Wai Kam, Ian C K Wong, Wei Zhang, Alvin L Young, Clement C Tham, Chi Pui Pang, Li Jia Chen, Patrick Ip, Jason C Yam. (2026). Retinal nerve fibre layer, and ganglion cell layer thicknesses in children with ADHD: associations with subtypes and symptom severity.. BMC psychiatry. DOI: 10.1186/s12888-026-08422-1

Consulta la pubblicazione originale ↗